Factors associated with referrals for directly observed treatment and unsuccessful treatment
The International Journal of Tuberculosis and Lung Disease · 2024
DOI: 10.5588/ijtld.23.0396 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2024. Verfasst von Y D González Diaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Serveis Clínics, Barcelona. Hauptthemen laut MEDLINE: Directly Observed Therapy, Referral and Consultation. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
OBJECTIVE
To describe the characteristics of people indicated for directly observed treatment (DOT) in Spain, and the factors associated with unsuccessful treatment.
METHODS
This was a multicentre observational study based on a prospective follow-up of patients over 18 years old diagnosed with TB between 2006 and 2019 from the registry of the Programa Integrado de Investigación en Tuberculosis (PII-TB). Sociodemographic and clinical variables were collected. Adjusted odds ratios (aORs) were calculated for the indication of DOT and for having an unsuccessful treatment.
RESULTS
A total of 7,883 patients were included. The indication of DOT was associated with being homeless (aOR 5.93, 95% CI 3.03–11.59), inactivity status (aOR 2.55, 95% CI 2.02–3.23), alcohol consumption (aOR 1.94, 95% CI 1.51–2.48), parenteral drug use (aOR 1.77, 95% CI 1.06–2.95) and HIV diagnosis (aOR 1.96, 95% CI 1.16–3.29). Unsuccessful treatment was associated with having an HIV diagnosis (aPR 2.31, 95% CI 1.31–4.08), having a worse clinical and radiological evolution (clinical progression: APR 15.59, 95% CI 8.21–29.60; radiological progression: aPR 12.84, 95% CI 6.46–25.52), need for hospitalisation (aPR 1.73, 95% CI 1.10–2.73), unsatisfactory tolerability (aPR 2.82, 95% CI 1.49–5.29), the existence of difficulties in understanding the prescribed treatment (aPR 1.92, 95% CI 1.21–3.06), as well as worse treatment satisfaction (aPR 7.27, 95% CI 4.32–12.24).
CONCLUSION
The prioritisation of vulnerable populations is a key aspect to carry out the new Global Plan to End TB 2023–2030. In these groups DOT indication should be increased to ensure adherence and patient follow-up and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Serveis Clínics, Barcelona.
- Agència de Salut Pública de Barcelona, Servei d'Epidemiologia, Barcelona, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid.
- Serveis Clínics, Barcelona, Agència de Salut Pública de Barcelona, Servei d'Epidemiologia, Barcelona.
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Programa Integrado de Investigación en Tuberculosis (PII-TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR)…
- Serveis Clínics, Barcelona, Agència de Salut Pública de Barcelona, Servei d'Epidemiologia, Barcelona, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Programa Integrado de I…
Zitieren
APA
Diaz, Y. D. G., Palma, D., Vargas-Leguás, H., Rodrigo, T., Molina-Pinargorte, I., Casas, X., Forcada, N., Santiago, J., Altet, N., & Millet, J. P. (2024). Factors associated with referrals for directly observed treatment and unsuccessful treatment. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.23.0396
Vancouver
Diaz YDG, Palma D, Vargas-Leguás H, Rodrigo T, Molina-Pinargorte I, Casas X, et al. Factors associated with referrals for directly observed treatment and unsuccessful treatment. The International Journal of Tuberculosis and Lung Disease. 2024. doi:10.5588/ijtld.23.0396
BibTeX
@article{Diaz2024,
author = {Diaz, Y D González and Palma, D and Vargas-Leguás, H and Rodrigo, T and Molina-Pinargorte, I and Casas, X and Forcada, N and Santiago, J and Altet, N and Millet, J-P},
title = {Factors associated with referrals for directly observed treatment and unsuccessful treatment},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2024},
doi = {10.5588/ijtld.23.0396}
}
EUVIMED